Dr. Sharon E. Nunez, MD

Dr. Nunez practices at Cleveland Clinic Indian River Dermatology - HOPD in Vero Beach, Florida.

Dr. Nunez's NPI, 1245379239, was assigned on February 6, 2007. Dr. Nunez graduated from Lewis Katz School of Medicine in 2001. Dr. Nunez's New Mexico license number on file is MD2005-0052.

Dr. Nunez's primary practice is Cleveland Clinic Indian River Dermatology - HOPD, at 1155 35th Ln, Vero Beach, FL 32960.

Dr. Nunez's primary practice is Cleveland Clinic Indian River Dermatology - HOPD in Vero Beach, Florida. Dr. Nunez is also affiliated with Cleveland Clinic Indian River Hospital. The medical group on file is Cleveland Clinic Indian River Hospital. Dmand AI also links Dr. Nunez to 1 more hospital, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nunez practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Nunez's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Nunez is board certified in rheumatology by the American Board of Internal Medicine. Dr. Nunez has a license on file in New Mexico.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, gout, joint arthropathy, lupus, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Dr. Nunez treats.

CMS data shows 158 Medicare services from Dr. Nunez across 4 procedure codes in 2023, for 19 Medicare patients. Medicare paid $8,160 for them.

CMS counts 19 Medicare patients who saw Dr. Nunez in 2024. The largest group is 85 and over, with 0 patients. 75% of them have arthritis, and 68% have high blood pressure. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nunez's median patient age at 65, with 73% women.

In 2024, Dr. Nunez wrote 525 Medicare Part D claims for 93 patients. 66% of them were for generic drugs. CMS names the drug for 406 of them, across 17 drugs with 11 or more claims each, at $737,802 in total drug cost. In 2023, CMS named 884 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Nunez for performance year 2024, reported as part of a group. Dr. Nunez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nunez as offering telehealth.

Dmand AI links 14 papers to Dr. Nunez, published from 2008 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Injections, Intra-Articular, Pain Measurement and Scleroderma, Systemic. Dr. Nunez has published most often in Int J Rheum Dis. Dr. Nunez's most frequent co-authors are Wilmer L. Sibbitt, MD, Maheswari Muruganandam, MBBS and Roderick A. Fields, MD.

CMS Open Payments shows 65 general payments to Dr. Nunez from 12 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $307.

Dr. Nunez graduated from Lewis Katz School of Medicine in 2001.

Dr. Nunez is in network with 3 carriers, including Blue Cross Blue Shield of Massachusetts, Elevance and Regence Health Plans. PPO plans come from the most carriers, 3. Check the plan with the practice before a visit.